Atherosclerosis and Hyperlipidemia
Mohammed Sallam , Hossameldin Hassan , Derek Connolly , et al
Nicolas M Van Mieghem, Joost Daemen
Joost Daemen, Allen Jeremias, Ziad A Ali et al
Video Series
Lale Tokgözoğlu, Kausik Ray, Ulrich Laufs, et al
Video Series
Lale Tokgözoğlu, Kausik Ray, Ulrich Laufs, et al
Ahmet Fuat, Jim Moore, Gary Ford, et al
Media
Nicolas M Van Mieghem, Joost Daemen
Joost Daemen, Allen Jeremias, Ziad A Ali et al
Video Series
Lale Tokgözoğlu, Kausik Ray, Ulrich Laufs, et al
Ahmet Fuat, Gary Ford, Kausik Ray, et al
Gurleen Kaur, Michelle O'Donoghue
Media
Ahmet Fuat, Gary Ford, Kausik Ray, et al
Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al
Joost Daemen, Allen Jeremias, Ziad A Ali et al
Nina Barnett, Yassir Javaid, Paresh Parmar et al
Articles
Dyslipidemia: Current Therapies and Guidelines for Treatment
Citation:
US Cardiology Review 2017;11(1):10–5
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views: 30163
- Downloads: 37
- Citations: 5
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease
Citation:
US Cardiology Review 2017;11(1):16–7
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views: 635
- Downloads: 2
Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial
Citation:
US Cardiology Review 2017;11(1):18–9
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views: 883
- Downloads: 2
Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy
Citation:
US Cardiology Review 2017;11(1):31–6
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views: 4632
- Downloads: 10
- Citations: 1